Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications

Recruiting Observational Study
Preeclampsia Preterm Birth Pregnancy Complications Fetal Anomalies
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
7,845 (estimated)
Sponsor
CHU de Quebec-Universite Laval · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * (specific to each study) Exclusion Criteria: * pregnant women \<18 years old at recruitment * negative fetal heart at recruitment * women not able to provide an informed consent to the study
Contacts

Emmanuel Bujold, MD, MSc

418-525-4444

emmanuel.bujold@crchudequebec.ulaval.ca

CONTACT

Sylvie Tapp, MSc

418-525-4444

sylvie.tapp@crchudequebec.ulaval.ca

CONTACT